| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 403.21 | 8.5% |
| Total Income | 444.90 | 4.3% |
| Expenditure | 323.28 | 6.2% |
| PBT | 121.62 | 0.9% |
| Net Profit | 93.08 | 1.4% |
| OPM | 26.32% | 0.78pp |
| NPM | 20.92% | 1.18pp |
| EPS | 9.19 | 3.0% |
Poly Medicure Ltd Reports Q1 FY26 Results: 4.8% YoY Consolidated Revenue Growth; 20.1% Domestic Market Revenue Growth
08 Aug 2025 · 8 Aug 2025, 03:15 pm
Summary
Poly Medicure Ltd, India’s leading Medical Device company, announced its unaudited consolidated and standalone financial results for the quarter ended on June 30, 2025. The company reported a 4.8% YoY growth in consolidated revenue and a 20.1% YoY growth in domestic market revenue. The renal care business maintained its strong growth trajectory, delivering a robust 46.2% YoY growth. The company also signed two contract manufacturing contracts and established a wholly owned subsidiary in Brazil.
Key Highlights
- 1
Q1 FY26 Consolidated Revenue growth of 4.8% on a YoY basis
- 2
Q1 FY26 revenue growth in domestic market of 20.1%
- 3
Renal care business delivered a robust 46.2% YoY growth
- 4
A total of 1350+ stents were successfully implanted between April to July 2025
- 5
Initiated India’s First international Clinical registry of 2000 patients
- 6
Signed two contract manufacturing contracts with companies based in US and Hong Kong
- 7
Established a wholly owned subsidiary in Brazil
Management Comments
Mr. Himanshu Baid
Managing Director, Poly Medicure Limited
We are pleased to share that we started the year on a steady note, with our Domestic revenue continuing to demonstrate strong growth momentum. This is supported by a healthy operating margin, enhanced PAT performance and significant product innovations—all while continuing to invest in sustainability, scale, and future capacity through R&D and green initiatives. Our renal division continues to grow at a robust pace, and with the commercialization of our Critical Care and Cardiology division last year, we are further expanding our presence in the larger Medical Devices industry. While short term challenges persist due to geopolitical tensions and recent tariff changes, we remain confident about the long term opportunity in for the Indian Medical Devices sector and continue to position ourselves strongly to capture that. We remain steadfast to our vision of “Serving people through innovative healthcare solutions”.
Informational and educational content only. Not investment advice.